News

Vir Biotechnology

Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.

NEWS ARTICLES

National Academy of Medicine: “An effective pandemic preparedness and response system is possible”

The New York Times: “Flu Season Is Coming. Here’s How to Prepare.”

The Hill: “Nation warned to brace for a difficult flu season”

Member Op-Ed: “It’s More Than ‘Just the Flu'”

STAT News: “Push to double up on Covid booster and flu shot may have a downside, experts caution”

U.S. News: “Another Reason to Get the Flu Shot: Lowered Risk for Stroke”

News

Vir Biotechnology

NEWS ARTICLES

National Academy of Medicine: “An effective pandemic preparedness and response system is possible”

The New York Times: “Flu Season Is Coming. Here’s How to Prepare.”

The Hill: “Nation warned to brace for a difficult flu season”

Member Op-Ed: “It’s More Than ‘Just the Flu'”

STAT News: “Push to double up on Covid booster and flu shot may have a downside, experts caution”

U.S. News: “Another Reason to Get the Flu Shot: Lowered Risk for Stroke”

Coalition Antitrust Policy

© 2022 Coalition to Stop Flu. All Rights Reserved.